Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1D1 | P20393 | 5/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | ESRRG | P62508 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18674519 | 0.95 | NR1D1 (0.32) | NR1D1NR1H3L3MBTL1ADRB3 | |
| SCHEMBL5007664 | 0.84 | NR1D1 (0.36) | NR1D1NR1H3AKT1 | |
| SCHEMBL18979341 | 0.81 | NR1D1 (0.35) | NR1D1NR1H3AKT1 | |
| SCHEMBL17200937 | 0.81 | NR1D1 (0.35) | NR1D1NR1H3AKT1 | |
| SCHEMBL3398146 | 0.79 | PPARG (0.30) | L3MBTL1 | |
| SCHEMBL26885902 | 0.78 | NR1D1 (0.33) | NR1D1NR1H3 | |
| SCHEMBL10367552 | 0.77 | ACACB (0.37) | NR1D1NR1H3 | |
| SCHEMBL6027858 | 0.76 | NR1D1 (0.34) | NR1D1NR1H3 | |
| SCHEMBL17200916 | 0.75 | ACACB (0.35) | NR1D1NR1H3 | |
| SCHEMBL15618181 | 0.75 | ACACB (0.35) | NR1D1NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10365286-B2 | Chromophoric structures for lanthanide chelates | RADIOMETER TURKU OY (FI) | 2019-07-30 | — | — | US | disclosed |
| EP-3137573-B1 | NEW CHROMOPHORIC STRUCTURES FOR LANTHANIDE CHELATES FIELD OF THE INVENTION | RADIOMETER TURKU OY (FI) | 2018-08-01 | — | — | EP | disclosed |
| US-20170089913-A1 | NEW CHROMOPHORIC STRUCTURES FOR LANTHANIDE CHELATES | RADIOMETER TURKU OY (FI) | 2017-03-30 | — | — | US | disclosed |
| US-8216856-B2 | Luminescent lanthanide labelling reagents and their use | ABACUS DIAGNOSTICA OY (FI) | 2012-07-10 | — | — | US | disclosed |
| EP-1658282-B1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2010-10-27 | — | — | EP | disclosed |
| EP-1658282-A1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2006-05-24 | — | — | EP | disclosed |
| US-20050084451-A1 | Novel chelating agents and chelates and their use | WALLAC OY | 2005-04-21 | — | — | US | disclosed |
| WO-2005021538-A1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050084451-A1 | Novel chelating agents and chelates and their use | DNPEP, CNBP, CLTA | NR1D1 4298/4885NR1H3 4286/4885L3MBTL1 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.